. Mapping of TFAM-228pBpa cross-links to mtRNAP (related to Figure 1) C. Fine mapping of the 228pBpa-TFAM cross-linking using CNBr.
CNBr cleavage of 33 P-labeled ∆119 mtRNAP. The labeled mtRNAP was treated with CNBr as described in Experimental Procedures. The products of the reaction were resolved using 4-12%
Bis-Tris MES-SDS gel (Invitrogen). Positions of SeeBlue protein standards (Invitrogen) are indicated to left. The bands were assigned based on their relative mobility in PAGE and theoretical molecular weight. Note that the cleavage at M482 residue is about 10 times less efficient than at the other methionines. Auto labeling of PKA enzyme (NEB) results in appearance of a low intensity band in both control and experimental lanes.
A. Cross-links at 217 and 228 have different mobility in SDS-PAGE. The pre-ICs (50 nM) were assembled with 32 P-labeled mtRNAP, LSP and 217pBpaTFAM or 228pBpaTFAM and UV irradiated for 30 min. The products of the reaction were resolved using 6% Tris-glycine SDS PAGE.
B. Mapping of the 228pBpa-TFAM cross-link using hydroxylamine. The pre-ICs were assembled using 32 P-labeled mutant mtRNAP having a single NG pair at position 443 and 217pBpa or 228pBpa-TFAM. The complexes were treated with hydroxylamine for 2-4 h at 43 0 C prior (lanes 1,2, 7 and 8) or after (lanes 3-6) UV-irradiation, and the products of the reaction resolved using 4-12% E. Purification of cross-linked species on Ni-agarose column. The pre-IC were formed using tag-less 32 P-labeled ∆108 mtRNAP (res 109-1230) in which an additional methionine residue (M473) was introduced and his-tagged pBpa228-TFAM. After UV-irradiation, the cross-linking reaction was passed through Ni-agarose column, washed 6 times with denaturing solution (6M urea, 1M NaCl) and the cross-link eluted with 0.2 mM imidazole (lane 'E'). 
C, D.
Mutations in the C-terminus of TFAM affect its activity. In vitro transcription assay was performed as described in Material and Methods using the LSP promoter template.
E. Summary of transcription activity of various TFAM mutants. Cross-linking mapping with CNBr (cleaves after Met residues) was performed under "single-hit" conditions (19, 20), i.e. when each TFB2M molecule was cleaved only once, on average. Cleavage of a Cterminally 32 P-labeled TFB2M generated a characteristic C-terminal pattern of the radiolabeled products ( Figure 2A, lanes 4,5) . Note a similar intensity of the cleavage products of TFB2M generated by CNBr.
When TFB2M-mtRNAP cross-link is cleaved, the cross-linked products have much larger molecular weights due to addition of the mtRNAP peptides (mtRNAP is also cleaved and generates unlabeled products) and thus appear shifted on the SDS gel (lanes 2,3 in Figure 2A ). The mobility of non-cross- 2 and 3) . MtRNAP is depicted as a ribbon (NTD, dark green; palm, light green; fingers, pink; intercalating hairpin, purple; PPR domain, slate; unassigned helix, sand). A Mg 2+ ion (orange) was placed according to a T7 RNAP structure. TFAM is shown in red (ribbon). The TFAM and -49 DNA cross-linking sites in mtRNAP are indicated in yellow. 2 Activity of mtRNAP mutants was measured using transcription assay. The reactions contained 50 nM LSP template, 50 nM mtRNAP, 50 nm TFB2M, 50 nM of TFAM and nucleotide mixtures described in Experimental Procedures.
Explanation of the cross-link mapping data. Cleavage of the NG59 TFB2M mutant generates a single labeled fragment that corresponds to the N-terminal region of TFB2M (lanes 2-3, note accumulation of the product), suggesting that DNA-TFB2M cross-link site is located between residues 1-59 (B, lanes
3 ND-activity was not determined. Table S1 . Activity of mtRNAP variants having substitution in the region of the D helix
